• Home
  • HCN Trends
  • Contact Us

Search Articles

Cardiology Covid-19 Dermatology Endocrinology General Interest Hematology Infectious Disease Neurology Oncology Pediatrics Psychiatry Pulmonology Rheumatology Surgery Uncategorized
acetaminophen actemra adverse events anemia antibody anxiety azithromycin bipolar disorder bleeding blog brain tumor breast cancer burnout Cancer capecitabine capmatinib cervical cancer chloroquine chronic pain clinical trials cloroquine CME compensation coronary artery disease coronavirus cost covid-19 death diagnosis doctors dosing drug interactions efficacy erlotinib exercise FDA/regulation fever filters glioblastoma green tea guidelines hemophilia hiv hospital hydroxychloroquine ibrutinib ibuprofen immunity induction chemotherapy infectious disease influenza ipilimumab irinotecan iron-deficiency anemia isn letrozole leukemia Lung cancer malaria mask Masks mbc MDS medical cannabis medical school Medicine mesothelioma metastatic colorectal cancer Myelodysplastic Syndromes myeloid leukemia nivolumab nsclc olaparib osimertinib outcomes pandemic patient safety patients pediatrics perjeta physicians podcast practice practice management prevention procedure prostate cancer radiation remdesivir research/studies respirators respiratory retevmo rucaparib sars SCLC selinexor selpercatinib sorafenib stroke Survival/Mortality symptoms syndrome telemedicine testing therapy thrombosis thyroid cancer time tnbc tocilizumab trastuzumab treatment vaccine venetoclax xpovio

December 15, 2020 | Oncology
ASH 2020; Happy Docs; mRNA Technology

M3 These Doctor Specialties are the Happiest

The year 2020 has been long and trying, and MDLinx conducted a COVID-19 survey of US physicians and found that nearly half of doctors are rethinking their careers. Still, it is important to consider that many physicians still find joy and fulfillment in practicing medicine. But who are the happiest? Here is what the Medscape […]

American Society of Hematology ASH Annual Meeting: Does High-Dose Methotrexate Protect the CNS in High-Risk DLBCL?

The possible answer was presented during the 2020 ASH Annual Meeting, bringing into question whether current recommendations for prophylactic intravenous high-dose methotrexate — the most widely adopted method for CNS relapse prevention — are appropriate for all patients at high risk of a CNS relapse.

Everyday Health Want to Know More About mRNA Before Your COVID Jab?

The first doses of COVID-19 vaccines will be arriving in a few weeks, both of which use messenger RNA (mRNA) technology to induce an immune response. Biologically, mRNA is transcribed from DNA and travels into a cell’s cytoplasm where it is translated by ribosomes into proteins. For those who want more information on the history […]
  • © Healthcare Communications Network
  • Privacy Policy